African Consortium for Cancer Clinical Trials (AC³T)

Have you helped conduct a clinical trial in Africa?

BIO Ventures for Global Health (BVGH) is profiling African clinical trial sites as part of the African Consortium for Cancer Clinical Trials (AC³T).

Click here to learn more.

AC³T: Access through Clinical Trials

Under the purview of AAI, BVGH launched the African Consortium for Cancer Clinical Trials (AC³T) to foster and implement cancer clinical trials led by investigators in Africa. AC³T is designed to build clinical trial capacity and address the cancer data gap in Africa while increasing access to prioritized cancer diagnostics, medicines, and quality treatment for African patients.

Learn more about AC³T.

 

AC3T Group AAI

AC³T Goals

> Increase access to new and established cancer medicines and technologies through clinical trials.

> Address the cancer data gap in African ethnicities.

> Galvanize support for African investigator-initiated cancer clinical trials at "ready now" cancer centers and hospitals.

> Build clinical trial capacity in "ready soon" cancer centers and hospitals.

COMING SOON!

A new AC³T clinical trials platform will showcase African institutions' clinical trial capacity. If you want your organization featured on the platform, please complete the AC³T checklist.

For more information on the platform or checklist, email dseymour@bvgh.org.

AAI STAT News Op-ed

Our Partners

Driven by Africa - for Africa

To learn more about the African Access Initiative, contact Katy Graef